抗生素结合剂:使用分子特洛伊木马来克服抗药性
Xi Li1, Siyuan Dong2, Qi Pan3
1Department of Vascular and Thyroid Surgery, the First Affiliated Hospital of China Medical University, Shenyang, China.
概括
抗菌素耐药性 (AMR) 是一个全球危机. 小说"特洛伊木马"抗生素结合物通过增强药物输送和疗效,显示出治疗耐药性感染的前景.
科学领域:
- 微生物学 微生物学
- 药物发现 药物发现 药物发现
- 生物技术是生物技术.
背景情况:
- 抗菌素耐药性 (AMR) 是一个日益增长的全球健康威胁,由多药耐药细菌驱动.
- 在开发中的新抗生素显著缺乏,加剧了AMR危机.
- 迫切需要新的抗菌疗法来对抗耐药性病原体.
研究的目的:
- 审查使用"特洛伊木马"战略对抗生素结合物的当前研究.
- 探索使用单克隆抗体 (mAbs),抗菌 (AMPs) 和 siderophores作为结合元件.
- 总结抗生素对抗药物耐药性感染的合理性,机制和证据.
主要方法:
- 审查关于抗生素结合剂及其机制的现有文献.
- 对抗生素结合物的疗效的临床前和临床数据的分析.
- 讨论临床翻译的挑战和未来方向.
主要成果:
- 抗生素结合物可以改善药物进入细菌细胞,并增强对抗性菌株的疗效.
- "特洛伊木马"战略可以重新利用现有的药物,克服毒性问题.
- 证据支持与mAbs,AMPs和 siderophores对抗耐药病原体的结合物的活性.
结论:
- 抗生素结合剂代表了传统抗微生物药物治疗多药耐药性 (MDR) 感染的有希望的替代品.
- 克服临床翻译方面的挑战需要对抗药物耐药性机制和相关领域的进展有更深入的了解.
- 未来的发展需要提高抗生素结合物的选择性,效力和安全性.
相关概念视频
Combined Effects of Drugs: Synergism
3.6K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.6K
Antibiotic Selection
51.9K
Overview
51.9K
Phase II Conjugation Reactions: Overview
110
Conjugation, a key component of phase II biotransformation reactions, is a vital process in drug detoxification. It involves transferring endogenous substances like glucuronic acid, sulfate, and glycine to drugs or their metabolites formed in phase I reactions. These conjugation reactions, often catalyzed by specific enzymes, transform potentially harmful metabolites into inactive, water-soluble forms easily excreted in urine or bile. By enhancing polarity and eliminating pharmacological...
110
Defense Against Bacterial Pathogens
1.3K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.3K
Bacterial Transformation
54.9K
In 1928, bacteriologist Frederick Griffith worked on a vaccine for pneumonia, which is caused by Streptococcus pneumoniae bacteria. Griffith studied two pneumonia strains in mice: one pathogenic and one non-pathogenic. Only the pathogenic strain killed host mice.
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
Griffith made an unexpected discovery when he killed the pathogenic strain and mixed its remains with the live, non-pathogenic strain. Not only did the mixture kill host mice, but it also contained living pathogenic bacteria that...
54.9K
Targets for Drug Action: Overview
5.9K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
5.9K


